1
|
New low-viscosity overlay medium for viral plaque assays.
|
Virol J
|
2006
|
3.92
|
2
|
Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected].
|
J Virol
|
2003
|
2.87
|
3
|
Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium.
|
J Virol
|
2006
|
2.80
|
4
|
Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P.
|
J Virol
|
2003
|
2.57
|
5
|
Crystal structure of the borna disease virus nucleoprotein.
|
Structure
|
2003
|
2.30
|
6
|
Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor.
|
EMBO Rep
|
2003
|
1.85
|
7
|
Ectodomain shedding of the glycoprotein GP of Ebola virus.
|
EMBO J
|
2004
|
1.73
|
8
|
Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length.
|
FEBS Lett
|
2003
|
1.62
|
9
|
Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP).
|
Virus Res
|
2004
|
1.54
|
10
|
Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium.
|
Virology
|
2007
|
1.44
|
11
|
Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors.
|
J Virol
|
2010
|
1.40
|
12
|
The role of myristoylation in the membrane association of the Lassa virus matrix protein Z.
|
Virol J
|
2006
|
1.27
|
13
|
Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication.
|
J Virol
|
2010
|
1.20
|
14
|
Inhibition of influenza virus infection in human airway cell cultures by an antisense peptide-conjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2.
|
J Virol
|
2010
|
1.15
|
15
|
MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
|
Vaccine
|
2009
|
1.13
|
16
|
Taxonomic reorganization of the family Bornaviridae.
|
Arch Virol
|
2014
|
1.09
|
17
|
Lassa virus glycoprotein signal peptide displays a novel topology with an extended endoplasmic reticulum luminal region.
|
J Biol Chem
|
2004
|
1.06
|
18
|
Role of the transmembrane domain of marburg virus surface protein GP in assembly of the viral envelope.
|
J Virol
|
2007
|
1.06
|
19
|
Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics.
|
J Med Chem
|
2010
|
1.05
|
20
|
Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses.
|
J Virol
|
2012
|
1.03
|
21
|
Viral protein determinants of Lassa virus entry and release from polarized epithelial cells.
|
J Virol
|
2010
|
1.02
|
22
|
Molecular mechanisms of interspecies transmission and pathogenicity of influenza viruses: Lessons from the 2009 pandemic.
|
Bioessays
|
2011
|
1.00
|
23
|
TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice.
|
J Virol
|
2014
|
0.99
|
24
|
Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.
|
J Biol Chem
|
2012
|
0.98
|
25
|
The role of single N-glycans in proteolytic processing and cell surface transport of the Lassa virus glycoprotein GP-C.
|
Virol J
|
2006
|
0.96
|
26
|
Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium.
|
Pathog Dis
|
2013
|
0.94
|
27
|
Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants.
|
PLoS Negl Trop Dis
|
2009
|
0.91
|
28
|
Crystal structure of the Borna disease virus matrix protein (BDV-M) reveals ssRNA binding properties.
|
Proc Natl Acad Sci U S A
|
2009
|
0.91
|
29
|
Maturation cleavage within the ectodomain of Lassa virus glycoprotein relies on stabilization by the cytoplasmic tail.
|
FEBS Lett
|
2010
|
0.87
|
30
|
Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation.
|
Biochem J
|
2013
|
0.84
|
31
|
RNA induced polymerization of the Borna disease virus nucleoprotein.
|
Virology
|
2009
|
0.84
|
32
|
Oligomerization and assembly of the matrix protein of Borna disease virus.
|
FEBS Lett
|
2005
|
0.84
|
33
|
The hemagglutinin: a determinant of pathogenicity.
|
Curr Top Microbiol Immunol
|
2014
|
0.83
|
34
|
Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections.
|
Vaccine
|
2012
|
0.83
|
35
|
Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication.
|
J Virol
|
2009
|
0.82
|
36
|
Activation of influenza A viruses by host proteases from swine airway epithelium.
|
J Virol
|
2013
|
0.81
|
37
|
Identification of the amino terminal subunit of the glycoprotein of Borna disease virus.
|
FEBS Lett
|
2002
|
0.81
|
38
|
The role of oligomerization for the biological functions of the arenavirus nucleoprotein.
|
Arch Virol
|
2013
|
0.81
|
39
|
Maturation of Borna disease virus glycoprotein.
|
FEBS Lett
|
2005
|
0.79
|
40
|
Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses.
|
Vaccine
|
2011
|
0.78
|
41
|
Crystallization and preliminary X-ray analysis of the matrix protein of Borna disease virus.
|
Acta Crystallogr D Biol Crystallogr
|
2002
|
0.77
|
42
|
Gangliosides are not essential for influenza virus infection.
|
Glycoconj J
|
2006
|
0.77
|
43
|
Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT.
|
Bioorg Med Chem Lett
|
2011
|
0.77
|
44
|
The microtubule motor protein KIF13A is involved in intracellular trafficking of the Lassa virus matrix protein Z.
|
Cell Microbiol
|
2013
|
0.75
|